301206 Stock Overview
Engages in the research and development, production, and sale of erythritol and compound sugar products in China.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Shandong Sanyuan Biotechnology Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥25.73 |
| 52 Week High | CN¥37.42 |
| 52 Week Low | CN¥20.80 |
| Beta | 0.77 |
| 1 Month Change | -20.83% |
| 3 Month Change | 5.62% |
| 1 Year Change | -16.30% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -25.89% |
Recent News & Updates
Recent updates
Shareholder Returns
| 301206 | CN Food | CN Market | |
|---|---|---|---|
| 7D | -5.6% | -2.6% | -1.8% |
| 1Y | -16.3% | -14.7% | -14.0% |
Return vs Industry: 301206 underperformed the CN Food industry which returned -14.7% over the past year.
Return vs Market: 301206 underperformed the CN Market which returned -14% over the past year.
Price Volatility
| 301206 volatility | |
|---|---|
| 301206 Average Weekly Movement | 6.6% |
| Food Industry Average Movement | 5.7% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in CN Market | 10.2% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 301206's share price has been volatile over the past 3 months.
Volatility Over Time: 301206's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 427 | Baohua Cheng | www.sanyuanbz.com |
Shandong Sanyuan Biotechnology Co.,Ltd. engages in the research and development, production, and sale of erythritol and compound sugar products in China. Its products are used in table sugar, flavored sugar, and beverages; candy and chocolate food; baked food; health food; medical supplies; cosmetic products; chemical products; and other applications.
Shandong Sanyuan Biotechnology Co.,Ltd. Fundamentals Summary
| 301206 fundamental statistics | |
|---|---|
| Market cap | CN¥5.22b |
| Earnings (TTM) | CN¥75.31m |
| Revenue (TTM) | CN¥575.12m |
69.1x
P/E Ratio9.1x
P/S RatioIs 301206 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301206 income statement (TTM) | |
|---|---|
| Revenue | CN¥575.12m |
| Cost of Revenue | CN¥539.77m |
| Gross Profit | CN¥35.35m |
| Other Expenses | -CN¥39.96m |
| Earnings | CN¥75.31m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.37 |
| Gross Margin | 6.15% |
| Net Profit Margin | 13.10% |
| Debt/Equity Ratio | 0% |
How did 301206 perform over the long term?
See historical performance and comparison